Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

NCT03715478 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: GSK2857916 with Pomalidomide and Dexamethasone

Sponsor

Canadian Myeloma Research Group

Collaborators

[object Object]